4//SEC Filing
THURMAN RANDY H 4
Accession 0001209191-20-050564
CIK 0001649989other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 6:31 PM ET
Size
5.4 KB
Accession
0001209191-20-050564
Insider Transaction Report
Form 4
THURMAN RANDY H
Director
Transactions
- Purchase
Common Stock
2020-09-14$0.62/sh+10,000$6,200→ 11,875 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Reflects a 1-for-8 reverse stock split effected by the Issuer on March 15, 2019 (the "Split Date"). The Reporting Person's previous ownership of 15,000 shares of common stock was adjusted to 1,875 shares of Common Stock on the Split Date.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001204059
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 6:31 PM ET
- Size
- 5.4 KB